Inhibition of BCL11B induces downregulation of PTK7 and results in growth retardation and apoptosis in T-cell acute lymphoblastic leukemia
Abstract T-cell acute lymphoblastic leukemia (T-ALL) is an aggressive subtype of leukemia with poor prognosis, and biomarkers and novel therapeutic targets are urgently needed for this disease. Our previous studies have found that inhibition of the B-cell leukemia/lymphoma 11B (BCL11B) gene could si...
Saved in:
Main Authors: | Kehan Li (Author), Cunte Chen (Author), Rili Gao (Author), Xibao Yu (Author), Youxue Huang (Author), Zheng Chen (Author), Zhuandi Liu (Author), Shaohua Chen (Author), Gengxin Luo (Author), Xin Huang (Author), Grzegorz K. Przybylski (Author), Yangqiu Li (Author), Chengwu Zeng (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2021-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
High expression of TMEM244 is associated with poor overall survival of patients with T-cell lymphoma
by: Cunte Chen, et al.
Published: (2022) -
Transcriptome-Based Co-Expression of BRD4 and PD-1/PD-L1 Predicts Poor Overall Survival in Patients With Acute Myeloid Leukemia
by: Cunte Chen, et al.
Published: (2021) -
Lower BCL11B expression is associated with adverse clinical outcome for patients with myelodysplastic syndrome
by: Xin Huang, et al.
Published: (2021) -
BRD4 inhibitor reduces exhaustion and blocks terminal differentiation in CAR-T cells by modulating BATF and EGR1
by: Songnan Sui, et al.
Published: (2024) -
TOX as a potential target for immunotherapy in lymphocytic malignancies
by: Chaofeng Liang, et al.
Published: (2021)